Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2019 | Vaso-occlusion, multi-cell adhesion & the HOPE study

Bart Biemond • 15 Jun 2019
EHA 2019
General Non-Malignant Sickle Cell Disease
HOPE

Bart Biemond, MD, PhD, Academic Medical Centre, Amsterdam, Netherlands, tells us about how multi-cell adhesion can lead to vaso-occlusion and also discusses the HOPE study (NCT03036813). This interview took place at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands.

More from Bart Biemond

1:39
SCD: Assessing bleeding severity in thrombocytopenic patients
Bart Biemond • 15 Jun 2019
1:18
SCD: incentive spirometry
Bart Biemond • 14 Jun 2019
1:53
Novel agents for sickle cell disease
Bart Biemond • 16 Jul 2018
2:42
An update on sickle cell disease treatment
Bart Biemond • 16 Apr 2018

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
2:01
The MDT in the new era of gene therapy for hemoglobinopathies
Mattia Algeri • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals